DRREDDYNSEDr. Reddy's Laboratories Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Wed, 16 Apr, 2025 · 08:58 IST

Dr. Reddy's Laboratories Limited has informed the Exchange about Rumour Verification - Regulation 30(11)

DRREDDY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.4%Reaction day
₹1156.00
prior close
₹1150.20
announcement price
After-mkt
timing
Nifty 100market · index membership as recorded later (tracked since Jun 2026)+0.5%-0.9% vs market
Pharmaceuticals peers, median of 146sector+0.7%-1.2% vs sector

On the reaction day the stock moved 0.9 pts less than Nifty 100 and 1.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.5
10m
+0.0
15m
+0.4
30m
+0.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.4+0.5-0.9+0.7-1.2
Next day
+0.6+2.1-1.5+1.2-0.6
2d
+1.8+3.4-1.6+1.9-0.1
3d
+1.7+3.6-1.9+2.1-0.5
4d
+2.3+4.3-1.9+3.1-0.7
5d
+4.2+3.9+0.3+4.2+0.0
1w
+4.0+4.0+0.0+0.2+3.8
15d
+0.2+2.2-2.0-3.0+3.2
1m
+6.3+7.0-0.7+3.3+3.0
2m
+16.8+6.9+9.9+4.4+12.3
3m
+9.0+8.2+0.8+7.9+1.0
UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 146Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Dr. Reddy's Laboratories has informed the stock exchange about a rumour verification process under SEBI Regulation 30(11). This regulation requires listed companies to confirm, deny, or clarify market rumours that are circulating about them in order to protect investors from misinformation. The specific nature of the rumour being verified is not disclosed in this headline filing. Typically, the company follows up with a detailed clarification or a statement on the matter. Shareholders should watch for the company's forthcoming response to the rumour in question.

Likely market impact

This is a procedural compliance filing and not an indication of any wrongdoing. However, it may cause short-term volatility if the underlying rumour is material, pending the company's official clarification.